Delisting riskPopularity #5,164
INAB · NASDAQ · Biotechnology

IN8bio (INAB)

Develops gamma-delta T-cell therapies and engagers for cancer and autoimmune disease.

$1.21
After hours+0.08 (+7.08%)
At close$1.13(+6.60%)